Twin Helix

Rapid test

Rapid test

Finally the non-invasive solution for mass screening of COVID19 Antigen

Discover more

The new Joysbio rapid nasal tests, are less invasive than rhino pharyngeal swabs and in 15 minutes they provide safe results, the high sensitivity of this product allows rapid detection even at very low concentrations.
Sensitivity 98,72%
Specificity 97,32%

Rapid test

Delicate, simple, fast, safe

The new rapid test for the detection of coronavirus antigen is a lateral flow chromatographic immunoassay test using a
double-staining system for the qualitative detection of SARS-COV-2 (nucleocapside-N protein) antigen in the upper respiratory tract.
The sale of Serological Tests and rapid swabs is intended only for healthcare professionals.
Therefore, we cannot sell and give information to private individuals. Tests may only be performed by medical personnel. By purchasing them, you declare under your own responsibility that you are a health care professional, or that you use them only with the help of specialised personnel.

Discover the benefits

Benefits at a glance

1


Nasal swab (less invasive than nasopharyngeal swab)

The new rapid nasal swabs are less invasive than Rhinopharyngeal swabs, as the swab only needs to be inserted 2.5 cm deep into both nostrils.

2


Results in 15 minutes on average

The results within minutes are ready to be used in a quick and efficient decision-making process

3


Customer service dedicated to the convention with Confindustria of Alessandria

A dedicated email to this service will enable you to receive assistance

4


Results in 15 minutes on average

The results within minutes are ready to be used in a quick and efficient decision-making process

5


Nasal swab (less invasive than nasopharyngeal swab)

The new rapid nasal swabs are less invasive than Rhinopharyngeal swabs, as the swab only needs to be inserted 2.5 cm deep into both nostrils.

6


Extraction buffers in individual bottles

It is the optimal solution to avoid wasting doses and to maintain the right level of sterility of the liquid.

7


Autofocus for bright field and fluorescence images

8


Cell concentration amplification (1.0E04 - 5.0E07 cells/ML) For single cell sequencing and CAR-T assay determinations.

9


Volume for counting up to 5.1 μl, reducing measurement error and CV per count

10


Slide options for up to 8 channels for high productivity

11


Data Safety and Security

The CountWire™ System reliably protects all from deletion, overwriting, alteration, and/or possible accidences.

12


Electronic Signature

All reports may be digitally signed and the electronic signature information includes the name and user ID of the signer, as well as the date, time and meaning of the signature.

13


User Access Control

The CountWire™ System establishes different roles and levels of access and privilege and only authorized ones may access the system with a user ID and password. Upon successful login, they can perform only functions assigned or privileged to the role/level

14


Quick and safe way to boost herd immunity

This new technology enables more laboratories, which until now did not have access to such complex analyses, to accelerate the race towards immunity from COVID 19

15


No virus and invitro cells

cPass™ does not require the use of viruses or cells, making the work safer for the researcher or laboratory technician.

16


Can be used in most laboratories

The absence of viruses does not require highly skilled operators and complex security laboratory procedures (biosafety level 3), thus significantly reducing costs and time to obtain results.

17


Significant reduction in time and costs

The advantage of using specific proteins instead of viruses or pseudo-viruses makes analysis operations much simpler and faster, saving a huge ammount of resources.

18


Accurate and fast

Another key advantage of the cPass™ technology is that it is a highly specific and sensitive and in the same time isotype- and species-independent.

Current antibody tests on the market are typically isotype-specific for just IgM or IgG, species specific for human antibodies only and cannot distinguish NAbs from other binding antibodies which do not possess neutralizing function.

19


high throughput

It can be easily adapted for high-throughput automated tests with serum or plasma, significantly increasing the fields of application.

20


A reliable partner that closely follows the whole FISR calendar and covers all procurement needs

21


Satisfaction level monitored through quarterly surveys

22


Strategic reserve of rapid test for all eventualities

23


Fast and customised deliveries

24


Extraction buffers in individual bottles

25


Nasal swab (less invasive than nasopharyngeal swab)

26


Can also be used with a nasopharyngeal swab

27


Results in 15 minutes on average

28


Sensitivity 98,72%

29


Specificity 97.32%

30


Economical solution for large-scale use

Downloads


© COPYRIGHT 2020 TWIN HELIX C.F. /P.IVA and n° Registro Imprese di Milano 05819650960 – REA Milano 1851394 Cap.Soc.Euro 50.000 i.v. - Società uninominale